US Patent Issued to CONJUSTAR (ZHUHAI) BIOLOGICS on Feb. 3 for "Tricyclic polypeptide conjugated drug and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,335, issued on Feb. 3, was assigned to CONJUSTAR (ZHUHAI) BIOLOGICS Co. LTD. (Zhuhai, China).

"Tricyclic polypeptide conjugated drug and use thereof" was invented by Huining Li (Shanghai), Jianhua Xia (Shanghai), Zhigan Jiang (Shanghai), Haiying He (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A tricyclic polypeptide conjugated drug and the use thereof are provided. Specifically provided are a compound as represented by formula (III), and a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprising a therapeutically or prophylactically effective amount of the compound or the pharmaceuticall...